Literature DB >> 10026358

Expression of skeletal muscle sarcoplasmic reticulum calcium-ATPase is reduced in rats with postinfarction heart failure.

A Simonini1, K Chang, P Yue, C S Long, B M Massie.   

Abstract

OBJECTIVE: To determine whether heart failure in rats is associated with altered expression of the skeletal muscle sarcoplasmic reticulum Ca2+-ATPase (SERCA).
METHODS: SERCA protein and mRNA were examined in the soleus muscles of eight female rats with heart failure induced by coronary artery ligation, six weeks after the procedure (mean (SEM) left ventricular end diastolic pressure 20.4 (2.2) mm Hg) and in six sham operated controls by western and northern analyses, respectively.
RESULTS: SERCA-2a isoform protein was reduced by 16% (112 000 (4000) v 134 000 (2000) arbitrary units, p < 0.001), and SERCA-2a messenger RNA was reduced by 59% (0.24 (0. 06) v 0.58 (0.02) arbitrary units, p < 0.001). Although rats with heart failure had smaller muscles (0.54 mg/g v 0.66 mg/g body weight), no difference in locomotor activity was observed.
CONCLUSIONS: These results may explain the previously documented abnormalities in calcium handling in skeletal muscle from animals with the same model of congestive heart failure, and could be responsible for the accelerated muscle fatigue characteristic of patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026358      PMCID: PMC1728966          DOI: 10.1136/hrt.81.3.303

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

1.  Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps.

Authors:  J Lytton; M Westlin; S E Burk; G E Shull; D H MacLennan
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

2.  Management of ectopic atrial tachycardia.

Authors:  K P Anderson
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

3.  Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.

Authors:  D M Mancini; G Walter; N Reichek; R Lenkinski; K K McCully; J L Mullen; J R Wilson
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

4.  Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat.

Authors:  D de la Bastie; D Levitsky; L Rappaport; J J Mercadier; F Marotte; C Wisnewsky; V Brovkovich; K Schwartz; A M Lompré
Journal:  Circ Res       Date:  1990-02       Impact factor: 17.367

5.  Alterations in contractility and intracellular Ca2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure.

Authors:  C L Perreault; H Gonzalez-Serratos; S E Litwin; X Sun; C Franzini-Armstrong; J P Morgan
Journal:  Circ Res       Date:  1993-08       Impact factor: 17.367

6.  Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance.

Authors:  J R Minotti; I Christoph; R Oka; M W Weiner; L Wells; B M Massie
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

7.  Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure.

Authors:  J R Minotti; P Pillay; L Chang; L Wells; B M Massie
Journal:  Circulation       Date:  1992-09       Impact factor: 29.690

8.  Skeletal muscle size: relationship to muscle function in heart failure.

Authors:  J R Minotti; P Pillay; R Oka; L Wells; I Christoph; B M Massie
Journal:  J Appl Physiol (1985)       Date:  1993-07

9.  Alterations of skeletal muscle in chronic heart failure.

Authors:  H Drexler; U Riede; T Münzel; H König; E Funke; H Just
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

Review 10.  Exercise intolerance in patients with chronic heart failure.

Authors:  M J Sullivan; M H Hawthorne
Journal:  Prog Cardiovasc Dis       Date:  1995 Jul-Aug       Impact factor: 8.194

View more
  6 in total

1.  Slowed relaxation and preserved maximal force in soleus muscles of mice with targeted disruption of the Serca2 gene in skeletal muscle.

Authors:  Cecilie Sjåland; Per Kristian Lunde; Fredrik Swift; Morten Munkvik; Madelene Ericsson; Marianne Lunde; Sigurd Boye; Geir Christensen; Øyvind Ellingsen; Ole M Sejersted; Kristin B Andersson
Journal:  J Physiol       Date:  2011-09-26       Impact factor: 5.182

Review 2.  Exercise capacity, physical activity, and morbidity.

Authors:  Danielle L Brunjes; Peter J Kennel; P Christian Schulze
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

Review 3.  Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?

Authors:  T A Rehn; M Munkvik; P K Lunde; I Sjaastad; O M Sejersted
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

4.  Reduced knee extensor function in heart failure is not explained by inactivity.

Authors:  Michael J Toth; Anthony O Shaw; Mark S Miller; Peter VanBuren; Martin M LeWinter; David W Maughan; Philip A Ades
Journal:  Int J Cardiol       Date:  2009-03-27       Impact factor: 4.164

5.  Alterations in the calcium homeostasis of skeletal muscle from postmyocardial infarcted rats.

Authors:  Gyula Péter Szigeti; János Almássy; Mónika Sztretye; Beatrix Dienes; László Szabó; Péter Szentesi; Guy Vassort; Sándor Sárközi; László Csernoch; István Jóna
Journal:  Pflugers Arch       Date:  2007-06-09       Impact factor: 3.657

6.  Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure.

Authors:  Tuba Khawaja; Aalap Chokshi; Ruiping Ji; Tomoko S Kato; Katherine Xu; Cynthia Zizola; Christina Wu; Daniel E Forman; Takeyoshi Ota; Peter Kennel; Hiroo Takayama; Yoshifumi Naka; Isaac George; Donna Mancini; Christian P Schulze
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-08-07       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.